Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Return on Assets (2016 - 2026)

Pharma-Bio Serv's Return on Assets history spans 14 years, with the latest figure at 0.01% for Q1 2026.

  • For Q1 2026, Return on Assets rose 2.0% year-over-year to 0.01%; the TTM value through Jan 2026 reached 0.01%, up 2.0%, while the annual FY2025 figure was 0.01%, 4.0% up from the prior year.
  • Return on Assets reached 0.01% in Q1 2026 per PBSV's latest filing, up from 0.01% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.08% in Q3 2023 to a low of 0.2% in Q3 2022.
  • Average Return on Assets over 5 years is 0.01%, with a median of 0.01% recorded in 2025.
  • Peak YoY movement for Return on Assets: dropped -30bps in 2022, then increased 28bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.05% in 2022, then skyrocketed by 33bps to 0.07% in 2023, then plummeted by -173bps to 0.05% in 2024, then skyrocketed by 83bps to 0.01% in 2025, then grew by 22bps to 0.01% in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Return on Assets are 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025).